Targeting Burkitt lymphoma with a tumor cell–specific heptamethine carbocyanine‐cisplatin conjugate

BACKGROUND: Burkitt lymphoma is a fast‐growing mature B cell malignancy, whose genetic hallmark is translocation and activation of the c‐myc gene. Prompt multiagent immunochemotherapy regimens can have favorable outcomes, but prognosis is poor in refractory or relapsed disease. We previously identif...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer
Autori principali: Mrdenovic, Stefan, Zhang, Yi, Wang, Ruoxiang, Yin, Lijuan, Chu, Gina Chia‐Yi, Yin, Liyuan, Lewis, Michael, Heffer, Marija, Zhau, Haiyen E., Chung, Leland W. K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2019
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6618854/
https://ncbi.nlm.nih.gov/pubmed/30840322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32033
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi